Author: digi

Import–Export GDP: Customs, Delays and Temperature Risk Controls Comprehensive Guide to Import–Export GDP: Managing Customs, Delays, and Temperature Risk Controls in the Pharma Supply Chain In global pharmaceutical distribution, ensuring compliance with Good Distribution Practice (GDP) during import-export operations is critical to maintain product integrity, particularly within the cold chain. This tutorial outlines a step-by-step…

Read More “Import–Export GDP: Customs, Delays and Temperature Risk Controls” »

Handling Product Returns: Visual Inspection, Storage and Decision-Making in Pharma Supply Chain Handling Product Returns: A Step-by-Step Guide for Visual Inspection, Storage, and Decision-Making in GDP Efficient and compliant management of product returns within the pharmaceutical supply chain is a critical component of Good Distribution Practice (GDP), especially when adhering to regulatory frameworks across the…

Read More “Handling Product Returns: Visual Inspection, Storage and Decision-Making” »

Reconciliation and Documentation for Returned Goods Comprehensive Step-by-Step Guide to Reconciliation and Documentation for Returned Goods in Pharma Supply Chain The management of returned goods within pharmaceutical supply chains necessitates rigorous adherence to Good Distribution Practice (GDP), comprehensive reconciliation procedures, and proper documentation to ensure product quality, patient safety, and regulatory compliance. This tutorial provides…

Read More “Reconciliation and Documentation for Returned Goods” »

Raw Material Supply Chain Risks: Vendor Qualification and Testing Comprehensive Step-by-Step Guide on Raw Material Supply Chain Risks, Vendor Qualification, and Testing Managing the pharmaceutical supply chain presents unique and critical challenges, especially concerning raw material sourcing, vendor qualification, and testing processes. Effective implementation of Good Distribution Practice (GDP), cold chain management, and warehousing controls…

Read More “Raw Material Supply Chain Risks: Vendor Qualification and Testing” »

Vendor Qualification Under GDP: Audit, Approval and Monitoring Vendor Qualification Under GDP: A Step-by-Step Guide to Audit, Approval, and Monitoring Ensuring compliance with Good Distribution Practice (GDP) during vendor qualification is critical for maintaining the integrity, safety, and quality of pharmaceutical products throughout the supply chain. Pharmaceutical companies operating in the US, UK, and EU…

Read More “Vendor Qualification Under GDP: Audit, Approval and Monitoring” »

Supplier Quality Agreements: Must-Have Clauses and Enforcement Essential Guide to Supplier Quality Agreements for GDP and Cold Chain Compliance Supplier Quality Agreements (SQAs) are pivotal documents within the pharmaceutical supply chain, especially given the complex regulatory environment surrounding GDP (Good Distribution Practice), cold chain management, and warehousing. For pharmaceutical manufacturers and distributors operating across the…

Read More “Supplier Quality Agreements: Must-Have Clauses and Enforcement” »

Third-Party Logistics (3PL) Management: Oversight and Performance Monitoring Comprehensive Step-by-Step Guide to Third-Party Logistics (3PL) Management for Pharma Supply Chain Compliance In today’s pharmaceutical industry landscape, reliance on Third-Party Logistics (3PL) providers is critical for efficient and compliant pharma supply chain management. With increasing regulatory scrutiny from agencies such as the FDA, EMA, MHRA, and…

Read More “Third-Party Logistics (3PL) Management: Oversight and Performance Monitoring” »

Third-Party Logistics (3PL) Management: Oversight and Performance Monitoring Comprehensive Step-by-Step Guide to Managing Third-Party Logistics (3PL) for Pharma Supply Chains Including Cold Chain Compliance Effective management of Third-Party Logistics (3PL) providers is a critical component in ensuring the integrity, quality, and regulatory compliance of the pharmaceutical supply chain. This is especially paramount for products requiring…

Read More “Third-Party Logistics (3PL) Management: Oversight and Performance Monitoring” »

Outsourcing to Global Logistics Partners: Maintaining Quality Oversight Maintaining Quality Oversight When Outsourcing to Global Logistics Partners The pharmaceutical supply chain relies heavily on Good Distribution Practice (GDP) to ensure the integrity, safety, and quality of medicinal products throughout their journey from manufacturer to end user. With an increase in outsourcing logistics functions, including warehousing,…

Read More “Outsourcing to Global Logistics Partners: Maintaining Quality Oversight” »

Outsourcing to Global Logistics Partners: Maintaining Quality Oversight Maintaining Quality Oversight When Outsourcing to Global Logistics Partners For pharmaceutical companies operating in the United States, United Kingdom, and European Union, maintaining robust quality oversight throughout the pharma supply chain is critical. The increasing reliance on third-party logistics (3PL) providers and global warehousing partners necessitates rigorous…

Read More “Outsourcing to Global Logistics Partners: Maintaining Quality Oversight” »